National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

polyglutamate camptothecin
A therapeutic formulation consisting of camptothecin, an alkaloid isolated from the Chinese tree Camptotheca acuminata, conjugated with polyglutamate. During the S phase of the cell cycle, camptothecin selectively stabilizes topoisomerase I-DNA covalent complexes, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery. Conjugation with polyglutamate renders this agent more water soluble and less toxic than the parent molecule. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:PG-CPT
Code name:CT-2106



Previous:poly-TLR agonist polyantigenic vaccine CADI-05, polyamine analogue PG11047, polyethylene glycol 3350-based laxative, polyethyleneglycol-7-ethyl-10-hydroxycamptothecin, Polygam S/D
Next:polymeric camptothecin prodrug XMT-1001, Polymox, Polyphenon E Ointment, polysaccharide-K, polyunsaturated fatty acid

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov